Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 16, 2004

View Archived Issues

Leptin may regulate energy balance by posttranslational modulation of the melanocortin pathway

Antiparasitic drug effective against SARS in vitro

Array BioPharma and QLT collaborate in cancer therapeutics discovery

Caprion awarded NIAID grant for biodefense research

Acuity files IND for phase I trials of Cand5

Novel promising agent for inflammatory bowel disease and glomerulonephritis therapy

Baxter signs as contract manufacturer for Morphotek's MORAb-003

GB Therapeutics acquires license for Chiesi's NMDA antagonist

European orphan drug designation for TheraCIM hR3

A role for doxycycline in cardioprotection

Geranylgeranylacetone effective against coronary dysfunction in vivo

Mechanisms of melatonin cardioprotection

Pharmacia presents new CDK inhibitors

Novel factor Xa and/or factor VIIa inhibitors under study at Aventis

Teijin claims new vitamin D3 analogues for osteoporosis and other disorders

Ajinomoto presents new prodrugs of factor Xa inhibitors

New aminobenzophenone prodrugs and their use in skin inflammatory disorders

New immunosuppressants in early development at Sumitomo

Novel PPARdelta agonists and their use in diabetes, dyslipidemia, etc.

Encouraging topline data from phase II ramoplanin study

Zimycan meets endpoints in phase III study for Candida diaper dermatitis

BioDelivery Sciences to acquire Arius Pharmaceuticals

TheraQuest meets with U.S., U.K., Canadian authorities regarding TQ-1011

Evotec OAI and Seikagaku collaborate in inflammatory disease

Novartis exercises option to Vernalis' lead Hsp90 oncology program

Prous Science Award supports research in the field of microwave-assisted chemistry

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.